Background: Choosing Wisely is a high-profile campaign seeking to reduce the use of low-value care. We investigated the impact of a Choosing Wisely Canada recommendation against using a combination of angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) for the management of hypertension, heart failure or diabetic nephropathy on population-level use of these medications in British Columbia, Canada.
Methods: We identified all people (any age) who were continuously registered with BC's Medical Service Plan between 2010 and 2017 with the targeted conditions. Using prescription claims data and an interrupted time-series analysis, we estimated the number of people on combination therapy per month, the proportion of days covered (PDC) by combination therapy per month and proportion of all combination prescriptions started per month in the 2 years before and after the introduction of the recommendation on Oct. 29, 2014.
Results: Of 1 104 593 people (mean age 65 yr, standard deviation 16 yr) in our study cohort, 4.6% were exposed to combination therapy, largely prescribed by family physicians (84%). The number of people on combination therapy and the PDC were declining before the recommendation, but the proportion of combination prescriptions started in the 2 years before the recommendation was increasing. After the recommendation, we observed no statistically significant changes in any outcome. The pre-existing downward trend of the monthly number of people decelerated (16.8, 95% confidence interval [CI] 14.0 to 19.5) and the proportion of prescriptions started increased (0.13%, 95% CI 0.08% to 0.18%).
Interpretation: The Choosing Wisely Canada recommendation against using a combination of ACE inhibitors and ARBs was not associated with reduced combination therapy use in the targeted conditions. The observed pre-existing declines in this practice questions the process of selecting recommendations, and the optimal implementation and value of Choosing Wisely campaigns without other reinforcing interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828945 | PMC |
http://dx.doi.org/10.9778/cmajo.20210185 | DOI Listing |
J Hosp Med
January 2025
Divisions of General Internal Medicine and Hospital Medicine, Sinai Health, Toronto, Canada.
Emerg Med Australas
February 2025
Department of Emergency Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
The continued use of low-value care interventions is a persisting challenge across the healthcare system despite targeted international efforts to reduce their use. These practices result in considerable economic and carbon costs. We present a model used to successfully de-implement four low-value care practices in a tertiary ED in Victoria, Australia.
View Article and Find Full Text PDFJAMA Surg
January 2025
Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin.
CMAJ
January 2025
Temerty Faculty of Medicine (Tilley, Kim, Lass), University of Toronto; Departments of Medicine (Silverstein) and Neurology (Masellis), Sunnybrook Health Sciences Centre, Toronto, Ont.
BMJ Evid Based Med
December 2024
Religion Studies, Lehigh University, Bethlehem, Pennsylvania, USA
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!